Tarsus Pharmaceuticals (TARS) — Research Snapshot as of 2026-10-03

Current Profile

Tarsus Pharmaceuticals is a commercial-stage biopharmaceutical company headquartered in Irvine, California, trading on Nasdaq (TARS), focused on eye care. [4][18] As of early October 2026, the stock traded around $73.00, down notably from a September 28 close of $83.21, within a 52-week range of $53.89–$91.53. [5][17][18] Shares outstanding stand at roughly 43.88 million. [4][18]